Prevention of type 2 diabetes: An update

被引：9
作者：
Farag A. [1 ]
Karam J. [1 ]
Nicasio J. [1 ]
McFarlane S.I. [1 ]
机构：
[1] Division of Endocrinology, Veterans Administration, New York Harbor Healthcare System, Brooklyn, NY 11209
来源：
Current Diabetes Reports | 2007年 / 7卷 / 3期
关键词：
Metformin; Rosiglitazone; Valsartan; Ramipril; Acarbose;
D O I：
10.1007/s11892-007-0032-4
中图分类号：
学科分类号：
摘要：
With the rising tide of the diabetes epidemic leading to increased morbidity and mortality (primarily from cardiovascular diseased), together with failure to control the disease and its associated complications, prevention of diabetes appears to be the logical option for curbing this epidemic. Several trials have been completed, and others ongoing, using various strategies for diabetes prevention. In this review, we provide an update on diabetes prevention strategies, highlighting the rationale behind such interventions, together with an outlook of the ongoing efforts that are likely to provide additional options for patients at risk for diabetes. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：200 / 207
页数：7
相关论文
共 50 条
  • [21] Trending Modalities in Type 2 Diabetes Prevention
    Lundgrin, Erika L.
    Hatipoglu, Betul
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 : S187 - S192
  • [22] Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners
    Shibib, Lina
    Al-Qaisi, Mo
    Guess, Nicola
    Miras, Alexander
    Greenwald, Steve E.
    Pelling, Marc
    Ahmed, Ahmed
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 3111 - 3130
  • [23] The global agenda for the prevention of type 2 diabetes
    Herman, William H.
    NUTRITION REVIEWS, 2017, 75 : 13 - 18
  • [24] Type 2 diabetes mellitus and insulin resistance: Stroke prevention and management
    Kernan W.N.
    Inzucchi S.E.
    Current Treatment Options in Neurology, 2004, 6 (6) : 443 - 450
  • [25] Pharmacological Management of Type 2 Diabetes Mellitus: An Update
    El-Kaissi, Samer
    Sherbeeni, Suphia
    CURRENT DIABETES REVIEWS, 2011, 7 (06) : 392 - 405
  • [26] Evogliptin for the treatment option for type 2 diabetes: an update of the literature
    Zou, Ping
    Guo, Mingxing
    Hu, Jingbo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (06) : 747 - 757
  • [27] Pharmacological approaches to the prevention of type 2 diabetes mellitus
    Majety, Priyanka
    Lozada Orquera, Faustina Alejandra
    Edem, Dinesh
    Hamdy, Osama
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] Leveraging Genetics to Advance Type 2 Diabetes Prevention
    Florez, Jose C.
    PLOS MEDICINE, 2016, 13 (07)
  • [29] Prevalence, predisposition and prevention of type II diabetes
    Cheng D.
    Nutrition & Metabolism, 2 (1)
  • [30] Primärprävention beim Diabetes mellitus Typ 2Primary prevention of diabetes mellitus type 2
    B. Gallwitz
    Der Internist, 2004, 45 (Suppl 1): : S15 - S22
12345